Wedbush Maintains Neutral on Staar Surgical, Raises Price Target to $26

Benzinga Newsdesk www.benzinga.com Positive 53.7%

Neg 0% Neu 0% Pos 53.7%

Wedbush analyst Michael Piccolo maintains Staar Surgical (NASDAQ:STAA) with a Neutral and raises the price target from $21 to $26.